MDM2 and exocrine pancreatic carcinoma: These results suggested that MDM2 was affirmed as a target of miR-579-3p and regulated by HCG11/miR-579-3p, insinuating that HCG11, miR-579-3p and MDM2 may establish a ceRNA network to regulate the progression of pancreatic carcinoma.